Aeon raises €8.2M in a seed round to enhance preventive healthcare with full-body check-ups, making it accessible to the masses.

Swiss preventative health company Aeon has closed a €8.2 million seed round for its platform for early detection and preventive healthcare. Aeon integrates full-body MRI, advanced blood biomarkers, and genetic insights into a single 60-minute check-up. They have maintained a 0 per cent false positive rate, a critical differentiator in a field plagued by overdiagnosis. The company’s technology aims to enable early detection of over 500 diseases and health risks.